Cargando…

How to continue lipid-lowering therapy in patients with coronary heart disease and severe liver dysfunction?: A case report of plaque regression by a combination of Chinese and Western Medicine

RATIONALE: Atherosclerotic cardiovascular disease (ASCVD), including coronary heart disease (CHD), atherosclerotic stroke and peripheral vascular disease, has become the most deadly chronic noncommunicable disease throughout the world in recent decades, while plaque regression could reduce the occur...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Dong, Xu, Xiang-Ru, Yue, Bo-Wen, Zhao, Li-Li, Yan, Shi-Hai, Qian, Yu-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824820/
https://www.ncbi.nlm.nih.gov/pubmed/31651893
http://dx.doi.org/10.1097/MD.0000000000017664
_version_ 1783464807558545408
author Yan, Dong
Xu, Xiang-Ru
Yue, Bo-Wen
Zhao, Li-Li
Yan, Shi-Hai
Qian, Yu-Liang
author_facet Yan, Dong
Xu, Xiang-Ru
Yue, Bo-Wen
Zhao, Li-Li
Yan, Shi-Hai
Qian, Yu-Liang
author_sort Yan, Dong
collection PubMed
description RATIONALE: Atherosclerotic cardiovascular disease (ASCVD), including coronary heart disease (CHD), atherosclerotic stroke and peripheral vascular disease, has become the most deadly chronic noncommunicable disease throughout the world in recent decades, while plaque regression could reduce the occurrence of ASCVD. Traditional Chinese Medicine (TCM) has been widely used for prevention and treatment of these diseases. In the perspective of TCM, phlegm and blood stasis are considered to be leading pathogenesis for CHD. Hence, activating blood circulation and dissipating phlegm, which is of great benefit to regress plaque, have been regarded as general principles in treatment. PATIENT CONCERNS: A 36-year-old man presented with a 3-month history of intermittent exertional chest pain. Coronary angiography revealed 60% stenosis of the proximal left anterior descending coronary artery. Liver function showed: alanine transaminase (ALT):627U/L, aspartate transaminase (AST):243U/L. DIAGNOSES: CHD and hepatitis B with severe liver dysfunction. INTERVENTIONS: The patient should have been treated with high-intensity statin therapy. Actually, due to severe liver dysfunction, Huazhirougan granule instead of statins was administered. In addition, he was treated with TCM according to syndrome differentiation for two and a half years. OUTCOMES: The chest pain disappeared and other symptoms alleviated as well after treatment. Coronary computed tomographic angiography revealed no stenosis in the proximal left anterior descending coronary artery. ALT and AST level returned to normal (ALT:45U/L,AST:24U/L). LESSONS: For patients with CHD and severe hepatic dysfunction, antilipidemic drugs such as statins are not recommended. This case suggested that TCM might fill a gap in lipid-lowering therapy. Thus, we could see that statins were not the only drug for plaque regression and the effect of TCM in treating coronary artery disease cannot be ignored.
format Online
Article
Text
id pubmed-6824820
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-68248202019-11-19 How to continue lipid-lowering therapy in patients with coronary heart disease and severe liver dysfunction?: A case report of plaque regression by a combination of Chinese and Western Medicine Yan, Dong Xu, Xiang-Ru Yue, Bo-Wen Zhao, Li-Li Yan, Shi-Hai Qian, Yu-Liang Medicine (Baltimore) 3400 RATIONALE: Atherosclerotic cardiovascular disease (ASCVD), including coronary heart disease (CHD), atherosclerotic stroke and peripheral vascular disease, has become the most deadly chronic noncommunicable disease throughout the world in recent decades, while plaque regression could reduce the occurrence of ASCVD. Traditional Chinese Medicine (TCM) has been widely used for prevention and treatment of these diseases. In the perspective of TCM, phlegm and blood stasis are considered to be leading pathogenesis for CHD. Hence, activating blood circulation and dissipating phlegm, which is of great benefit to regress plaque, have been regarded as general principles in treatment. PATIENT CONCERNS: A 36-year-old man presented with a 3-month history of intermittent exertional chest pain. Coronary angiography revealed 60% stenosis of the proximal left anterior descending coronary artery. Liver function showed: alanine transaminase (ALT):627U/L, aspartate transaminase (AST):243U/L. DIAGNOSES: CHD and hepatitis B with severe liver dysfunction. INTERVENTIONS: The patient should have been treated with high-intensity statin therapy. Actually, due to severe liver dysfunction, Huazhirougan granule instead of statins was administered. In addition, he was treated with TCM according to syndrome differentiation for two and a half years. OUTCOMES: The chest pain disappeared and other symptoms alleviated as well after treatment. Coronary computed tomographic angiography revealed no stenosis in the proximal left anterior descending coronary artery. ALT and AST level returned to normal (ALT:45U/L,AST:24U/L). LESSONS: For patients with CHD and severe hepatic dysfunction, antilipidemic drugs such as statins are not recommended. This case suggested that TCM might fill a gap in lipid-lowering therapy. Thus, we could see that statins were not the only drug for plaque regression and the effect of TCM in treating coronary artery disease cannot be ignored. Wolters Kluwer Health 2019-10-25 /pmc/articles/PMC6824820/ /pubmed/31651893 http://dx.doi.org/10.1097/MD.0000000000017664 Text en Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3400
Yan, Dong
Xu, Xiang-Ru
Yue, Bo-Wen
Zhao, Li-Li
Yan, Shi-Hai
Qian, Yu-Liang
How to continue lipid-lowering therapy in patients with coronary heart disease and severe liver dysfunction?: A case report of plaque regression by a combination of Chinese and Western Medicine
title How to continue lipid-lowering therapy in patients with coronary heart disease and severe liver dysfunction?: A case report of plaque regression by a combination of Chinese and Western Medicine
title_full How to continue lipid-lowering therapy in patients with coronary heart disease and severe liver dysfunction?: A case report of plaque regression by a combination of Chinese and Western Medicine
title_fullStr How to continue lipid-lowering therapy in patients with coronary heart disease and severe liver dysfunction?: A case report of plaque regression by a combination of Chinese and Western Medicine
title_full_unstemmed How to continue lipid-lowering therapy in patients with coronary heart disease and severe liver dysfunction?: A case report of plaque regression by a combination of Chinese and Western Medicine
title_short How to continue lipid-lowering therapy in patients with coronary heart disease and severe liver dysfunction?: A case report of plaque regression by a combination of Chinese and Western Medicine
title_sort how to continue lipid-lowering therapy in patients with coronary heart disease and severe liver dysfunction?: a case report of plaque regression by a combination of chinese and western medicine
topic 3400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824820/
https://www.ncbi.nlm.nih.gov/pubmed/31651893
http://dx.doi.org/10.1097/MD.0000000000017664
work_keys_str_mv AT yandong howtocontinuelipidloweringtherapyinpatientswithcoronaryheartdiseaseandsevereliverdysfunctionacasereportofplaqueregressionbyacombinationofchineseandwesternmedicine
AT xuxiangru howtocontinuelipidloweringtherapyinpatientswithcoronaryheartdiseaseandsevereliverdysfunctionacasereportofplaqueregressionbyacombinationofchineseandwesternmedicine
AT yuebowen howtocontinuelipidloweringtherapyinpatientswithcoronaryheartdiseaseandsevereliverdysfunctionacasereportofplaqueregressionbyacombinationofchineseandwesternmedicine
AT zhaolili howtocontinuelipidloweringtherapyinpatientswithcoronaryheartdiseaseandsevereliverdysfunctionacasereportofplaqueregressionbyacombinationofchineseandwesternmedicine
AT yanshihai howtocontinuelipidloweringtherapyinpatientswithcoronaryheartdiseaseandsevereliverdysfunctionacasereportofplaqueregressionbyacombinationofchineseandwesternmedicine
AT qianyuliang howtocontinuelipidloweringtherapyinpatientswithcoronaryheartdiseaseandsevereliverdysfunctionacasereportofplaqueregressionbyacombinationofchineseandwesternmedicine